Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk
Open Access
- 30 October 2018
- journal article
- research article
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 25 (5), 545-563
- https://doi.org/10.5603/cj.2018.0116
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provincesBMC Public Health, 2013
- Association of kidney disease with prevalent gout in the United States in 1988–1994 and 2007–2010Seminars in Arthritis and Rheumatism, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol DosingClinical Pharmacology & Therapeutics, 2012
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care & Research, 2012
- Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortalityRheumatology, 2012
- Genotype-based changes in serum uric acid affect blood pressureKidney International, 2012
- Decreased extra-renal urate excretion is a common cause of hyperuricemiaNature Communications, 2012
- Hyperuricemia and incident hypertension: A systematic review and meta‐analysisArthritis Care & Research, 2010
- Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trialThe Lancet, 2010
- Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathyFree Radical Biology & Medicine, 2006